Subscribe
The market is fretting about AI, but this FTSE 100 giant鈥檚 competitive moat remains robust
The Aim-traded stock offers investors the chance to play the big themes in drug development
The equipment company is profiting from an offshore spending boom and has other tricks up its sleeve
A range of new products and services means investors will soon reassess the consumer stock鈥檚 share price
The managers behind this company are looking to double shareholder returns within three to five years
The company is ahead of most rivals when it comes to margins and is planning smart acquisitions to entice shareholders
We published 100 深夜影院 of the Week last year 鈥� with some more than doubling in value
There鈥檚 no better way to diversify your income than with a discounted and reliable dividend payer
This Danish drug giant has suffered plenty of misfortune, but better times lie ahead
The managers strike the right balance between high payouts and making sure your capital grows too
